高通量筛选市场策略、顶级参与者、增长机会、2028 年分析和预测

  • Report Code : TIPBT00002085
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 246
Buy Now

High Throughput Screening Market Size & Growth Forecast 2028

Buy Now

高通量筛选市场规模预计将从 2021 年的 159.9747 亿美元增至 2028 年的 282.5571 亿美元。预计 2021 年至 2028 年期间的复合年增长率为 8.5%。

高通量筛选 (HTS) 是一种药物发现方法,可以自动测试针对特定生物靶标的各种化学或生物化合物。高通量筛选方法广泛应用于制药行业,利用机器人和自动化快速测试大量分子(通常是药物)的生物或生化活性。它们加速了靶标分析,因为可以很快以经济高效的方式筛选大规模化合物库。HTS 是评估药理靶标、药理分析受体(如 GPCR)和酶的激动剂和拮抗剂的宝贵工具。制药和生物技术行业增加对研发的投资以及高通量筛选市场引入技术先进的产品等因素预计将在未来几年推动市场增长。然而,高通量筛选的高成本、缺乏训练有素的专业人员以及检测开发的复杂性可能会阻碍未来几年市场的增长。

市场洞察

医药及生物技术产业增加研发投入

制药和生物技术公司增加研发支出,以及用于治疗心血管疾病、癌症、免疫系统疾病、代谢疾病和神经系统疾病等各种慢性疾病的重要药物管线是高通量筛选市场的主要驱动因素。几家大大小小的制药公司都参与开发和制造用于治疗多种危及生命的疾病的新分子。这导致人们选择采用自动化高通量筛选 (HTS) 方法来筛选庞大的化学库,以满足不断增加的药物靶分子的需求。例如,自动化高通量筛选系统一天可以筛选大约 10,000 到 100,000 个目标化合物。过去十年,制药和生物技术公司在高通量筛选技术方面投入了大量资金。例如,著名的 Millennium Pharmaceuticals, Inc. 和拜耳公司联盟在不到八个月的时间内成功发现了 18 个新的药物靶点,并将其中四个用于高通量筛选。该联盟采用基于基因组学研究的新型生产方法,以尽快将分子投入临床试验。高通量筛选一直被视为药物研发过程中的一项重要技术。例如,勃林格殷格翰公司已成功开发的先导化合物结构优化项目中,60%以上都归功于高通量筛选的成功实施。仅在美国,每年在高通量筛选产品和高通量筛选服务上的投入就超过25亿美元。大型制药公司每年在筛选技术上的投资高达3500万美元。这些投资中很大一部分用于开发新的检测方法。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

高通量筛选市场:

高通量筛选市场
  • High Throughput Screening Market
    复合年增长率(2021 - 2028 年)
    8.5%
  • 2021 年市场规模
    160 亿美元
  • 2028 年市场规模
    282.6 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 安捷伦科技公司
  • 艾克萨姆有限公司
  • 欧陆科技
  • 康宁公司
  • 分子设备有限责任公司
  • 汉密尔顿公司
  • 默克集团
  • Perkinelmer 公司
  • 帝肯集团

区域概况

High Throughput Screening Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

High Throughput Screening Market产品与服务
  • 耗材
  • 仪器
  • 配件
  • 软件
  • 服务
High Throughput Screening Market技术
  • 基于细胞的检测
  • 芯片实验室
  • 超高通量筛选
  • 生物信息学
  • 无标签技术
High Throughput Screening Market应用
  • 药物研发
  • 生化筛选
  • 生命科学研究
  • 其他应用
High Throughput Screening Market最终用户
  • 制药和生物技术公司
  • 学术和政府机构
  • 合同研究组织
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

用于药物发现和开发的筛选药物靶标数量不断增加,政府和研究机构的投资不断增加,将进一步推动 HTS 技术的应用。例如,2020 年 12 月,总部位于英国的独立综合药物发现和临床前合同研究组织 Sygnature Discovery 已投资约 412 万美元用于加强其高通量筛选 (HTS) 和转化肿瘤学服务。此外,美国 FDA、环境保护署和美国国立卫生研究院的合资项目“21 世纪毒理学”等项目使用自动化 HTS 测试化学品、配方和环境药物,进行广泛的毒理学检查并开发与疾病相关的特定途径以预测毒理学水平。此类项目将支持高通量筛选市场的扩散。

基于产品和服务的洞察

根据产品和服务,高通量筛选市场分为耗材、仪器、配件、软件和服务。2021 年,耗材部分占据了最大的市场份额,预计在预测期内将出现最快的复合年增长率。

 

报告范围



基于技术的见解

根据技术,高通量筛选市场细分为基于细胞的检测、芯片实验室、超高通量筛选、生物信息学和无标记技术。2021 年,基于细胞的检测部分占据了最大的市场份额,而芯片实验室部分预计在预测期内以最快的复合年增长率增长。

基于应用的洞察

根据应用,高通量筛选市场细分为药物发现、生化筛选、生命科学研究和其他应用。2021 年,药物发现领域占据了最大的市场份额,预计在预测期内将以最快的复合年增长率增长。

基于最终用户的洞察

根据最终用户,高通量筛选市场细分为制药和生物技术公司、学术和政府机构、合同研究组织 (CRO) 等。2021 年,制药和生物技术公司占据了最大的市场份额,而合同研究组织 (CRO) 预计在预测期内将以最快的复合年增长率增长。

在高通量筛选市场运营的各公司正在采用产品发布、并购、合作、产品创新和产品组合扩展等策略,以扩大其全球影响力、维护品牌名称并满足最终用户日益增长的需求。

高通量筛选市场报告范围

报告属性细节
2021 年市场规模160亿美元
2028 年市场规模282.6亿美元
全球复合年增长率(2021 - 2028)8.5%
历史数据2019-2020
预测期2022-2028
涵盖的领域按产品和服务
  • 耗材
  • 仪器
  • 配件
  • 软件
  • 服务
按技术分类
  • 基于细胞的检测
  • 芯片实验室
  • 超高通量筛选
  • 生物信息学
  • 无标签技术
按应用
  • 药物研发
  • 生化筛选
  • 生命科学研究
  • 其他应用
按最终用户
  • 制药和生物技术公司
  • 学术和政府机构
  • 合同研究组织
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 安捷伦科技公司
  • 艾克萨姆有限公司
  • 欧陆科技
  • 康宁公司
  • 分子设备有限责任公司
  • 汉密尔顿公司
  • 默克集团
  • Perkinelmer 公司
  • 帝肯集团
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

高通量筛选市场 – 按产品和服务

  • 耗材
    • 试剂和检测试剂盒
    • 实验室设备
  • 仪器
    • 液体处理系统
    • 检测系统
  • 配件
  • 软件
  • 服务

 

高通量筛选市场 – 按技术分类

  • 基于细胞的检测
  • 芯片实验室
  • 超高通量筛选
  • 生物信息学
  • 无标签技术
    • 表面等离子体共振
    • 反射干涉测量法
    • 等温滴定量热法
    • 差示扫描量热法
    • 微悬臂
    • 碳纳米管
    • 光子晶体
    • 其他的

 

高通量筛选市场——按应用划分

  • 药物研发
  • 生化筛选
  • 生命科学研究
  • 其他应用

 

高通量筛选市场 – 按最终用户划分

  • 制药和生物技术公司
  • 学术和政府机构
  • 合同研究组织(CRO)
  • 其他的

高通量筛选市场 – 按地区划分

  • 北美

    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲

    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)

    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲 (MEA)

    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲 (SAM)

    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

公司简介

  • 安捷伦科技公司
  • 艾克萨姆有限公司
  • 欧陆科技
  • 康宁公司
  • 分子设备有限责任公司
  • 汉密尔顿公司
  • 默克集团
  • Perkinelmer 公司
  • 帝肯集团
  • 赛默飞世尔科技公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the high-throughput screening market across the globe?

Key factors that are driving the growth of this market increase in investment in research and development by the pharmaceutical and biotechnology industry and the introduction of technologically advanced products in the high throughput screening.

Which end-user held the largest share in the high-throughput screening market?

The pharmaceutical and biotechnology companies segment dominated the global high-throughput screening market and accounted for the largest revenue share of 45.27% in 2021.

What are high-throughput screening?

High-throughput screening (HTS) is a drug discovery process that allows automated testing of large numbers of chemical and/or biological compounds for a specific biological target. High-throughput screening methods are extensively used in the pharmaceutical industry, leveraging robotics and automation to quickly test the biological or biochemical activity of a large number of molecules, usually drugs. They accelerate target analysis, as large-scale compound libraries can quickly be screened in a cost-effective way. HTS is a useful tool for assessing for instance pharmacological targets, pharmacologically profiling agonists and antagonists for receptors (such as GPCRs) and enzymes.

Which product and service led the high-throughput screening market?

The consumables segment dominated the global high-throughput screening market and held the largest revenue share of 44.85% in 2021.

What is the regional market scenario of high-throughput screening?

Global high-throughput screening market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for high-throughput screening. The US is estimated to hold the largest share in the high-throughput screening market during the forecast period. The growth of the market can be because of prevalence of various diseases, government support for biotechnology and increasing efforts in R&D activities as well as other activities undertaken by the market players operating in the market. In addition, technologically advanced products are likely to stimulate the growth of high-throughput screening market in North America. On the other hand, large pool of population suffering with chronic diseases, rapidly developing healthcare infrastructure, and intellectual capabilities of scientists and researchers in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.

Who are the key players in the high-throughput screening market?

The high-throughput screening market majorly consists of the players such Agilent Technologies, Inc., Axxam S.P.A., Eurofins Scientific, Corning Incorporated, Molecular Devices, LLC., Hamilton Company, Merck Group, Perkinelmer, Inc., Tecan Group and Thermo Fisher Scientific Inc. among others.

The List of Companies - High Throughput Screening Market

  1. Agilent Technologies, Inc.
  2. Axxam S.P.A.
  3. Eurofins Scientific
  4. Corning Incorporated
  5. Molecular Devices, LLC.
  6. Hamilton Company
  7. Merck Group
  8. Perkinelmer, Inc.
  9. Tecan Group
  10. Thermo Fisher Scientific Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..